Cargando…
CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration
Lung cancer is the leading cause of cancer mortality in the world. Although some advances in lung cancer therapy have been made, patient survival is still poor. The platelet-derived growth factor receptors (PDGFRs) and their ligands play critical roles in the regulation of many cancer cell processes...
Autores principales: | Xi, Yuling, Chen, Ming, Liu, Xinmin, Lu, Zhongmin, Ding, Yi, Li, Datong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090130/ https://www.ncbi.nlm.nih.gov/pubmed/25050066 http://dx.doi.org/10.2147/OTT.S62946 |
Ejemplares similares
-
Thymoquinone suppresses platelet‐derived growth factor‐BB–induced vascular smooth muscle cell proliferation, migration and neointimal formation
por: Zhu, Ning, et al.
Publicado: (2019) -
Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway
por: GAN, JIANTING, et al.
Publicado: (2013) -
MeCP2 inhibits proliferation and migration of breast cancer via suppression of epithelial‐mesenchymal transition
por: Jiang, Wei, et al.
Publicado: (2020) -
UVC irradiation suppresses platelet-derived growth factor-BB-induced migration in human pancreatic cancer cells
por: KAWAGUCHI, JUNJI, et al.
Publicado: (2011) -
Heat shock protein 90 inhibitor AUY922 attenuates platelet-derived growth factor-BB-induced migration and proliferation of vascular smooth muscle cells
por: Kim, Jisu, et al.
Publicado: (2020)